How has Tango Therapeutics's temporary equity shares authorized changed year-over-year?

Tango Therapeutics's temporary equity shares authorized decreased by 0.0% year-over-year, from 10M to 10M.

What is the long-term trend for Tango Therapeutics's temporary equity shares authorized?

Over 5 years (2020 to 2025), Tango Therapeutics's temporary equity shares authorized has grown at a 0.0% compound annual growth rate (CAGR), from 10M to 10M.

Tango Therapeutics TNGX Temporary Equity Shares Authorized

Temporary Equity Shares Authorized at other companies

BillionToOne, Inc. BLLN

0-100%

JAN

Janus Living JAN

20M—

Veradermics MANE

$0-100%

Flagstar Bank FLG

416.8M+0.4%

Essential UtilitiesWTRG

283.1M+3.0%

Valley National BankVLY

520.6K-80.2%

Other financials

Income statement

See full

Revenue--100%

Operating income-$48.8M-14.7%

Net income-$45.5M-14.1%

EPS (diluted)-$0.32+11.1%

Balance sheet

See full

Cash & equivalents$160.0M+162%

Total debt$32.8M-11.3%

Total equity$391.5M+135%

Total assets$435.8M+58.9%

Cash flow

See full

Operating cash flow-$44.4M-6.4%

CapEx-$2.0K-104%

Free cash flow-$44.4M-6.3%

Valuation

See full

Market cap$4.55B+1,915%

Profitability

See full

Operating margin-206.2%-61.0pp

Net margin-188.2%-55.4pp

FCF margin-250.1%-49.4pp

Returns & leverage

See full

Return on equity-38.4%-10.5pp

Debt / equity0.1×-0.1×

Current ratio27.4×+21.1×

Where this comes from

Reported directly by Tango Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:TemporaryEquitySharesAuthorized.

The official record: Tango Therapeutics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Tango Therapeutics's temporary equity shares authorized.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Tango Therapeutics's temporary equity shares authorized?: Tango Therapeutics (TNGX) reported temporary equity shares authorized of 10M in Q1 2026.
How has Tango Therapeutics's temporary equity shares authorized changed year-over-year?: Tango Therapeutics's temporary equity shares authorized decreased by 0.0% year-over-year, from 10M to 10M.
What is the long-term trend for Tango Therapeutics's temporary equity shares authorized?: Over 5 years (2020 to 2025), Tango Therapeutics's temporary equity shares authorized has grown at a 0.0% compound annual growth rate (CAGR), from 10M to 10M.